Guggenheim Capital’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-637
| Closed | -$97K | – | 2992 |
|
|
2016
Q3 | $97K | Buy |
637
+518
| +435% | +$78.9K | ﹤0.01% | 2732 |
|
|
2016
Q2 | $14K | Hold |
119
| – | – | ﹤0.01% | 2830 |
|
|
2016
Q1 | $14K | Buy |
119
+65
| +120% | +$7.65K | ﹤0.01% | 2850 |
|
|
2015
Q4 | $10K | Hold |
54
| – | – | ﹤0.01% | 2944 |
|
|
2015
Q3 | $9K | Buy |
+54
| New | +$9K | ﹤0.01% | 2930 |
|
|
2015
Q2 | – | Sell |
-80
| Closed | -$41K | – | 3104 |
|
|
2015
Q1 | $41K | Buy |
80
+3
| +4% | +$1.54K | ﹤0.01% | 2943 |
|
|
2014
Q4 | $41K | Buy |
+77
| New | +$41K | ﹤0.01% | 2926 |
|
|
2014
Q3 | – | Sell |
-101
| Closed | -$139K | – | 3075 |
|
|
2014
Q2 | $139K | Sell |
101
-10
| -9% | -$13.8K | ﹤0.01% | 2914 |
|
|
2014
Q1 | $155K | Buy |
111
+27
| +32% | +$37.7K | ﹤0.01% | 2891 |
|
|
2013
Q4 | $84K | Buy |
84
+11
| +15% | +$11K | ﹤0.01% | 2939 |
|
|
2013
Q3 | $76K | Sell |
73
-1
| -1% | -$1.04K | ﹤0.01% | 2831 |
|
|
2013
Q2 | $81K | Buy |
+74
| New | +$81K | ﹤0.01% | 2767 |
|